Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
5 studies found for:    Open Studies | "Coxsackievirus Infections"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Coxsackievirus Infections"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Study of Intratumoral CAVATAK™ (Coxsackievirus A21) and Ipilimumab in Patients With Advanced Melanoma
Condition: Melanoma
Interventions: Biological: CAVATAK;   Drug: Ipilimumab
2 Recruiting Phase I Study of Intratumoral CAVATAK™ and Pembrolizumab in Subjects With Advanced Melanoma
Condition: Melanoma
Interventions: Biological: CAVATAK;   Drug: Pembrolizumab
3 Recruiting Systemic Treatment Of Resistant Metastatic Disease Employing CVA21 and Pembrolizumab in Non-small Cell Lung Cancer and Bladder Cancer (STORM/ KEYNOTE-200)
Conditions: Non-small Cell Lung Cancer;   Castrate-resistant Prostate Cancer;   Melanoma;   Bladder Cancer
Intervention: Biological: CVA21
4 Not yet recruiting Safety, Three Batches Consistency and Immunity Duration of the Post-marketing Inactivated Enterovirus Type 71 (EV71) Vaccine in Children Aged 6-71 Months
Condition: Hand Foot and Mouth Disease
Interventions: Biological: the first batch vaccine;   Biological: the second batch vaccine;   Biological: the third batch vaccine
5 Recruiting Effect of Xiaoer Jiebiao Oral Liquid on Hand-foot-mouth Disease
Condition: Handfoot-mouth Disease
Interventions: Drug: Ribavirin plus Xiao'er jiebiao oral liquid;   Drug: Ribavirin

Study has passed its completion date and status has not been verified in more than two years.